Phase 3 HR+/HER2- Breast Cancer Clinical Trials

2 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 1–2 of 2 trials

Recruiting

Phase 3

Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer : a Randomized, Open-label, Parallel-controlled, Multi-center Phase III Study (NEOTORCH-BREAST04)

HR+/HER2- Breast Cancer

First Affiliated Hospital of Zhejiang University194 enrolled13 locationsNCT06977893

Recruiting

Phase 3

Apatinib Combined With cdk4/6i in First-line Treatment for HR+/HER2- SNF4 Subtype Breast Cancer

Advanced Breast CancerHR+/HER2- Breast Cancer

Fudan University184 enrolled1 locationNCT06447623